Posted on August 1st, 2012 by
A genetic mutation appears to be behind some cases of a common and aggressive brain cancer, researchers at Columbia University said, and targeting the abnormality with a drug prolonged the lives of mice with the condition…Robert Jenkins, professor of laboratory genetics at the Mayo Clinic, said it was particularly interesting that the researchers found the gene fusion in three patients. Glioblastoma is known to be genetically complex and when such abnormalities are found, they are often seen only in a single patient, said Dr. Jenkins, who wasn't involved in the research.
Wall Street Journal by Ron Winslow
You must be logged-in to the site to post a comment.